our current focus

Development of novel nanotherapeutic pipelines to enhance cancer-specific immunity

pdx news

  • COO of PDX Pharma presented at the MedInvest Biotech & Pharma Investor Conference in NYC

    4/15/2024
    read more

  • CEO of PDX Pharma inducted into the National Academy of Inventors for 2024

    3/25/2024
    read more

  • COO of PDX Pharma served as a reviewer on the NIH Scientific Review Panel

    3/14/2024
    read more

Copyright © 2017 PDX Pharmaceuticals, Inc. All rights reserved